phentermine has been researched along with reserpine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hoyer, I; Van Zwieten, PA | 1 |
Offermeier, J; Potgieter, B | 1 |
Campbell, D; LaPidus, JB; Patil, PN; Tye, A | 1 |
Borrelli, AR; Lawlor, RB; Panasevich, RE; Yelnosky, J | 1 |
Lapidus, JB; Patil, PN; Swamy, VC; Tye, A | 1 |
Eble, JN; Rudzik, AD | 1 |
Dunlop, PC; Johnson, GJ; Leis, LA; Weir, EK | 1 |
1 review(s) available for phentermine and reserpine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for phentermine and reserpine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
The central hypotensive action of amphetamine, ephedrine, phentermine, chlorphentermine and fenfluramine.
Topics: Amphetamine; Animals; Appetite Depressants; Blood Pressure; Cats; Chlorphentermine; Depression, Chemical; Ephedrine; Female; Fenfluramine; Haloperidol; Hypertension; Injections, Intravenous; Male; Phenethylamines; Phentermine; Reserpine; Sympatholytics; Vertebral Artery; Yohimbine | 1972 |
The possible central stimulant mechanisms of some appetite suppressants.
Topics: Amphetamine; Animals; Appetite Depressants; Catecholamines; Central Nervous System; Chlorphentermine; Diethylpropion; Dihydroxyphenylalanine; Drug Antagonism; Drug Synergism; Fenfluramine; Locomotion; Male; Methamphetamine; Methyltyrosines; Mice; Neurons; Pargyline; Phenethylamines; Phentermine; Rats; Reserpine; Stimulation, Chemical | 1972 |
Steric aspects of adrenergic drugs. II. Effects of DL isomers and desoxy derivatives on the reserpine-pretreated vas deferens.
Topics: Amphetamine; Animals; Appetite Depressants; Dopamine; Ephedrine; Epinephrine; In Vitro Techniques; Male; Mephentermine; Metaraminol; Methamphetamine; Norepinephrine; Octopamine; Phentermine; Phenylephrine; Rats; Reserpine; Synephrine; Tyramine; Vas Deferens | 1967 |
Pharmacology of phentermine.
Topics: Amphetamine; Animals; Appetite; Appetite Depressants; Blood Pressure; Body Weight; Cardiovascular System; Dextroamphetamine; Drug Synergism; Heart Rate; Mice; Phenethylamines; Phenoxybenzamine; Phentermine; Propranolol; Rats; Reserpine; Tachyphylaxis | 1969 |
Steric aspects of adrenergic drugs. 3. Norepinephrine potentiating effects of isomers of sympathomimetic amine in rat vas deferens and atria.
Topics: Amines; Amino Alcohols; Amphetamine; Animals; Cocaine; Dopamine; Drug Synergism; Ephedrine; Heart Atria; Male; Metaraminol; Methamphetamine; Muscle Contraction; Norepinephrine; Phentermine; Rats; Reserpine; Stereoisomerism; Sympathomimetics; Vas Deferens | 1969 |
The potentiation of pressor responses to tyramine by a number of amphetamine-like compounds.
Topics: Amphetamine; Animals; Blood Pressure; Chlorphentermine; Dogs; Drug Antagonism; Drug Synergism; Methamphetamine; Phentermine; Phenylpropanolamine; Pressoreceptors; Reserpine; Sympathomimetics; Tyramine | 1967 |
The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
Topics: Appetite Depressants; Blood Platelets; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Humans; Hydrogen-Ion Concentration; Norfenfluramine; Phentermine; Reserpine; Secretory Vesicles; Selective Serotonin Reuptake Inhibitors; Serotonin | 2003 |